| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of DNA binding | 1.95e-05 | 52 | 21 | 3 | GO:0043388 | |
| GeneOntologyBiologicalProcess | neural retina development | 1.46e-04 | 102 | 21 | 3 | GO:0003407 | |
| GeneOntologyBiologicalProcess | amacrine cell differentiation | 1.50e-04 | 18 | 21 | 2 | GO:0035881 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription regulatory region DNA binding | 1.86e-04 | 20 | 21 | 2 | GO:2000679 | |
| GeneOntologyBiologicalProcess | regulation of DNA binding | 2.09e-04 | 115 | 21 | 3 | GO:0051101 | |
| GeneOntologyCellularComponent | chromatin | 4.22e-04 | 1480 | 21 | 7 | GO:0000785 | |
| Pubmed | Egr-1 and Hipk2 are required for the TrkA to p75(NTR) switch that occurs downstream of IGF1-R. | 8.01e-06 | 7 | 22 | 2 | 18378044 | |
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 22445509 | ||
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 24709358 | ||
| Pubmed | Ptf1a determines horizontal and amacrine cell fates during mouse retinal development. | 1.37e-05 | 9 | 22 | 2 | 17075007 | |
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 19553286 | ||
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 23293286 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.62e-05 | 908 | 22 | 6 | 19274049 | |
| Pubmed | 2.09e-05 | 11 | 22 | 2 | 28356311 | ||
| Pubmed | 2.10e-05 | 263 | 22 | 4 | 34702444 | ||
| Pubmed | 2.51e-05 | 12 | 22 | 2 | 16354917 | ||
| Pubmed | Math5 is required for both early retinal neuron differentiation and cell cycle progression. | 2.97e-05 | 13 | 22 | 2 | 16690048 | |
| Pubmed | Ikaros confers early temporal competence to mouse retinal progenitor cells. | 2.97e-05 | 13 | 22 | 2 | 18940586 | |
| Pubmed | Expression of the LIM-homeodomain protein Isl1 in the developing and mature mouse retina. | 3.46e-05 | 14 | 22 | 2 | 17480014 | |
| Pubmed | Precocious retinal neurons: Pax6 controls timing of differentiation and determination of cell type. | 3.46e-05 | 14 | 22 | 2 | 15733660 | |
| Pubmed | Integral bHLH factor regulation of cell cycle exit and RGC differentiation. | 3.99e-05 | 15 | 22 | 2 | 29770538 | |
| Pubmed | 4.56e-05 | 16 | 22 | 2 | 17638910 | ||
| Pubmed | BARHL2 differentially regulates the development of retinal amacrine and ganglion neurons. | 4.56e-05 | 16 | 22 | 2 | 19339595 | |
| Pubmed | Math5 determines the competence state of retinal ganglion cell progenitors. | 5.16e-05 | 17 | 22 | 2 | 14623245 | |
| Pubmed | SOX2 is a dose-dependent regulator of retinal neural progenitor competence. | 6.49e-05 | 19 | 22 | 2 | 16651659 | |
| Pubmed | 7.21e-05 | 20 | 22 | 2 | 19088125 | ||
| Pubmed | 7.21e-05 | 20 | 22 | 2 | 38267260 | ||
| Pubmed | Zac1 functions through TGFbetaII to negatively regulate cell number in the developing retina. | 7.96e-05 | 21 | 22 | 2 | 17559664 | |
| Pubmed | Sip1 regulates the generation of the inner nuclear layer retinal cell lineages in mammals. | 7.96e-05 | 21 | 22 | 2 | 27385012 | |
| Pubmed | 7.96e-05 | 21 | 22 | 2 | 20969844 | ||
| Pubmed | Sequential Role of SOXB2 Factors in GABAergic Neuron Specification of the Dorsal Midbrain. | 7.96e-05 | 21 | 22 | 2 | 29867344 | |
| Pubmed | 8.76e-05 | 22 | 22 | 2 | 16038893 | ||
| Pubmed | MATH5 controls the acquisition of multiple retinal cell fates. | 8.76e-05 | 22 | 22 | 2 | 21087508 | |
| Pubmed | 9.59e-05 | 23 | 22 | 2 | 18367606 | ||
| Pubmed | Requirement for Bhlhb5 in the specification of amacrine and cone bipolar subtypes in mouse retina. | 1.05e-04 | 24 | 22 | 2 | 17092954 | |
| Pubmed | GDF11 controls the timing of progenitor cell competence in developing retina. | 1.14e-04 | 25 | 22 | 2 | 15976303 | |
| Pubmed | 1.23e-04 | 26 | 22 | 2 | 18787067 | ||
| Pubmed | miR-124a is required for hippocampal axogenesis and retinal cone survival through Lhx2 suppression. | 1.23e-04 | 26 | 22 | 2 | 21857657 | |
| Pubmed | 1.33e-04 | 27 | 22 | 2 | 22323600 | ||
| Pubmed | Rnf220 cooperates with Zc4h2 to specify spinal progenitor domains. | 1.53e-04 | 29 | 22 | 2 | 30177510 | |
| Pubmed | 1.53e-04 | 29 | 22 | 2 | 23652001 | ||
| Pubmed | 1.64e-04 | 30 | 22 | 2 | 15459106 | ||
| Pubmed | 1.64e-04 | 30 | 22 | 2 | 29137925 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.78e-04 | 457 | 22 | 4 | 32344865 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.95e-04 | 180 | 22 | 3 | 35198878 | |
| Pubmed | 1.99e-04 | 33 | 22 | 2 | 30917309 | ||
| Pubmed | 1.99e-04 | 33 | 22 | 2 | 20463215 | ||
| Pubmed | 2.01e-04 | 1429 | 22 | 6 | 35140242 | ||
| Pubmed | 2.12e-04 | 34 | 22 | 2 | 24026423 | ||
| Pubmed | Histone Deacetylase 3 Governs Perinatal Cerebral Development via Neural Stem and Progenitor Cells. | 2.12e-04 | 34 | 22 | 2 | 31569049 | |
| Pubmed | Roles for Dicer1 in the patterning and differentiation of the optic cup neuroepithelium. | 2.12e-04 | 34 | 22 | 2 | 21138975 | |
| Pubmed | 2.32e-04 | 191 | 22 | 3 | 31177093 | ||
| Pubmed | 2.38e-04 | 493 | 22 | 4 | 15368895 | ||
| Pubmed | Phox2a Defines a Developmental Origin of the Anterolateral System in Mice and Humans. | 2.94e-04 | 40 | 22 | 2 | 33238113 | |
| Pubmed | 3.24e-04 | 42 | 22 | 2 | 26876175 | ||
| Pubmed | 3.24e-04 | 42 | 22 | 2 | 30485816 | ||
| Pubmed | Onecut1 and Onecut2 redundantly regulate early retinal cell fates during development. | 3.40e-04 | 43 | 22 | 2 | 25228773 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 3.46e-04 | 544 | 22 | 4 | 28473536 | |
| Pubmed | 5.16e-04 | 53 | 22 | 2 | 27210758 | ||
| Pubmed | A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. | 6.18e-04 | 58 | 22 | 2 | 19734545 | |
| Interaction | MIXL1 interactions | 5.66e-05 | 11 | 21 | 2 | int:MIXL1 | |
| Interaction | F12 interactions | 6.79e-05 | 77 | 21 | 3 | int:F12 | |
| Interaction | DYRK1B interactions | 1.12e-04 | 91 | 21 | 3 | int:DYRK1B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q31 | 3.28e-03 | 178 | 22 | 2 | chr2q31 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.45e-06 | 197 | 22 | 4 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.90e-05 | 135 | 22 | 3 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-5|TCGA-Bladder / Sample_Type by Project: Shred V9 | 7.61e-05 | 169 | 22 | 3 | 9c4e83fe8225d16173a103bf5a57b17d623be923 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.44e-05 | 175 | 22 | 3 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-04 | 193 | 22 | 3 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.13e-04 | 193 | 22 | 3 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-04 | 193 | 22 | 3 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-04 | 194 | 22 | 3 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.20e-04 | 197 | 22 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.22e-04 | 198 | 22 | 3 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-04 | 198 | 22 | 3 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | distal-mesenchymal-Myofibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-04 | 198 | 22 | 3 | beef5075ba6dcd4d0a447bc4e57efcaf2e93c546 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-04 | 198 | 22 | 3 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | distal-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.23e-04 | 199 | 22 | 3 | b8f3cf5bcfde1066bdb49b14fdc842fe9692a6b7 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.23e-04 | 199 | 22 | 3 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 22 | 3 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| Disease | coffee consumption measurement, tea consumption measurement | 4.04e-06 | 44 | 21 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | C-X-C motif chemokine 11 measurement | 4.37e-05 | 14 | 21 | 2 | EFO_0008057 | |
| Disease | lymphocyte measurement | 7.67e-05 | 117 | 21 | 3 | EFO_0803546 | |
| Disease | heart failure | 2.97e-04 | 185 | 21 | 3 | EFO_0003144 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 4.69e-04 | 45 | 21 | 2 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 4.69e-04 | 45 | 21 | 2 | EFO_0004623, EFO_0004792 | |
| Disease | electrocardiography | 4.83e-04 | 530 | 21 | 4 | EFO_0004327 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 5.79e-04 | 50 | 21 | 2 | EFO_0022334 | |
| Disease | triglycerides to total lipids in large LDL percentage | 6.02e-04 | 51 | 21 | 2 | EFO_0022331 | |
| Disease | free cholesterol in large LDL measurement | 6.02e-04 | 51 | 21 | 2 | EFO_0022176 | |
| Disease | Ischemic stroke, fibrinogen measurement | 7.00e-04 | 55 | 21 | 2 | EFO_0004623, HP_0002140 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 7.52e-04 | 57 | 21 | 2 | EFO_0022284 | |
| Disease | cholesterol in IDL measurement | 7.78e-04 | 58 | 21 | 2 | EFO_0021899 | |
| Disease | cholesterol to total lipids in IDL percentage | 8.33e-04 | 60 | 21 | 2 | EFO_0022233 | |
| Disease | total lipids in IDL | 8.33e-04 | 60 | 21 | 2 | EFO_0022161 | |
| Disease | free cholesterol in IDL measurement | 8.61e-04 | 61 | 21 | 2 | EFO_0022181 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 9.47e-04 | 64 | 21 | 2 | EFO_0022253 | |
| Disease | sphingomyelin measurement | 9.70e-04 | 278 | 21 | 3 | EFO_0010118 | |
| Disease | juvenile idiopathic arthritis | 1.26e-03 | 74 | 21 | 2 | EFO_0002609 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.26e-03 | 74 | 21 | 2 | EFO_0022280 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 1.29e-03 | 307 | 21 | 3 | EFO_0004612, EFO_0020946 | |
| Disease | waist-hip ratio | 1.43e-03 | 1226 | 21 | 5 | EFO_0004343 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.46e-03 | 713 | 21 | 4 | EFO_0005689 | |
| Disease | lipoprotein measurement, phospholipid measurement | 1.66e-03 | 85 | 21 | 2 | EFO_0004639, EFO_0004732 | |
| Disease | intermediate density lipoprotein measurement | 1.74e-03 | 87 | 21 | 2 | EFO_0008595 | |
| Disease | left ventricular structural measurement | 1.78e-03 | 88 | 21 | 2 | EFO_0008205 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 2.03e-03 | 94 | 21 | 2 | EFO_0008595, EFO_0010351 | |
| Disease | small vessel stroke | 2.11e-03 | 96 | 21 | 2 | EFO_1001504 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 2.11e-03 | 96 | 21 | 2 | EFO_0004529, EFO_0008595 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TPTSYQAPKHFHIPA | 421 | O94929 | |
| TGSLPYPFHSHVPLH | 271 | Q03828 | |
| FQHHPYVTHIPSPTL | 2466 | Q6V0I7 | |
| STPHKYPSVHPETRH | 636 | A6QL63 | |
| PSYHHSPYKHAHIPA | 861 | Q9UPQ7 | |
| HYEPHFDHATSPSSP | 436 | Q7Z4N8 | |
| YSFPHNSPSHGTVHP | 1071 | Q9H2X6 | |
| ETSIKYVSHQHPSHP | 101 | Q8NFG4 | |
| SHVQPAYTNPPHMAH | 1231 | Q99700 | |
| PFLSQHPFPLHSSSH | 731 | Q15652 | |
| SPNPLSSPHLYHKQH | 696 | Q5XG87 | |
| STPPSQPTHRVHHFY | 161 | A8CG34 | |
| QPTHRVHHFYPSLPT | 166 | A8CG34 | |
| PRPPHTHSYTISHAT | 396 | Q5DX21 | |
| PPHSVKYTFPSTHHQ | 21 | Q9H4R4 | |
| QALKKTPYHPHPHVF | 201 | O00409 | |
| AHHHPTYEPKTVTTG | 111 | Q6UWJ8 | |
| QPLYAAPPHVIHHTT | 106 | A1KXE4 | |
| PHHSPFKPDATYHTM | 131 | Q12837 | |
| SVPVPGKPFHHTLYS | 1571 | Q8IZH2 | |
| HFYHPIHSNGTPIHT | 836 | Q2KHR2 | |
| HTHTHPSPTNPGYVV | 186 | O95416 | |
| PTHHYKSASDPIHTF | 1861 | Q562E7 | |
| SSHVFHVKPPPHAYS | 236 | Q13562 |